MODERN APPROACHES TO THE USE OF BETA-BLOCKERS IN CLINICAL PHARMACOLOGY

Аннотация

Cardiovascular diseases (CVDs) remain the leading cause of mortality worldwide and in the Republic of Kazakhstan. According to the World Health Organization (WHO), more than 17.9 million people die from CVDs every year (WHO, 2021). In Kazakhstan, the prevalence of arterial hypertension among the adult population exceeds 25%, which makes its control particularly relevant (Ministry of Health of the Republic of Kazakhstan, 2022).